http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26977215

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1041
issn 0918-2918
1349-7235
issueIdentifier 9
pageRange 1035-1041
publicationName Internal medicine (Tokyo, Japan)
startingPage 1035
bibliographicCitation Oh K, Ito S, Unno M, Kobayashi D, Azuma C, Abe A, Otani H, Ishikawa H, Nakazono K, Narita I, Murasawa A. The rate of decrease in the disease activity of rheumatoid arthritis during treatment with adalimumab depends on the dose of methotrexate. Intern Med. 2015;54(9):1035–41. doi: 10.2169/internalmedicine.54.4085. PMID: 25948343.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_237205d21c6205b6c00f5d060d43b640
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7484aca1626d71dbfb6ed68afca902f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5026f9ee0534cc28e3572c5d2c1ee82e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fe1890df3182c49dc678ee6177b0adc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dfa33032b38b594d556958680d324b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48afb56ed1d7286b9374275b1355703a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54dc0189234442010777a15c0ebe2d29
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9c30a9c16c05045ac8c46f00c8d96d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_703b9c68e869b4e4c22d7ad0c0b35dcb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c6ecb52653ebe7b4efc9cef40084406
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4a2c7bebbc7009320c88fbd8a636650
date 2015
identifier https://doi.org/10.2169/internalmedicine.54.4085
https://pubmed.ncbi.nlm.nih.gov/25948343
isPartOf https://portal.issn.org/resource/ISSN/0918-2918
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2038
https://portal.issn.org/resource/ISSN/1349-7235
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title The Rate of Decrease in the Disease Activity of Rheumatoid Arthritis during Treatment with Adalimumab Depends on the Dose of Methotrexate
discusses http://id.nlm.nih.gov/mesh/M0422769
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0013595
http://id.nlm.nih.gov/mesh/M0027742
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008727Q000008
http://id.nlm.nih.gov/mesh/D018501Q000008
http://id.nlm.nih.gov/mesh/D061067Q000008
http://id.nlm.nih.gov/mesh/D001172Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D018450
http://id.nlm.nih.gov/mesh/D000068879
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D001799
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D001172Q000503
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941

Showing number of triples: 1 to 51 of 51.